The Risk Management Plans (RMPs) are comprehensive documents submitted as part of the application dossiers for market approval of medicinal products. The RMP summaries contain information on the medicinal products′ safety profiles and explain the measures that are taken in order to further investigate and follow the risks as well as to prevent or minimise them.
The RMP summaries published are concise documents and do not claim to be exhaustive. As the RMPs are international documents, their summaries might differ from the content in the product information («Arzneimittelinformation») approved and published in Switzerland, e.g. by mentioning risks occurring in populations or indications not included in the Swiss authorisations. Please note that the reference documents, which are valid and relevant for the effective and safe use of medicinal products in Switzerland, are the «Arzneimittelinformationen» (see www.swissmedicinfo.ch) approved and authorised by Swissmedic.
The Marketing Authorisation Holders are responsible for the accuracy and correctness of the content of the here published RMP summaries.
Suche nach Präparatenamen
Results
0 Results found
Documents
Sorted...
Sorted by active substance
A - C
autologus anti CD 19 transduced CD3 cells (Tecartus®) RMP Summary (PDF, 183 kB, 26.10.2021)Version 1.0
D - F
Diphtheria-2/Tetanus/5AC Pertussis Vaccine (Adacel®) RMP Summary (PDF, 122 kB, 17.10.2022)Version 5.0
elasomeran (Spikevax®) / elasomeran / imelasomeran (Spikevax®) RMP Summary (PDF, 222 kB, 20.10.2022)Version 2.0
Emtricitabine Rilpivirine Tenofovir Alafenamide (Odefsey®): RMP (PDF, 104 kB, 01.05.2021)Version 3.0
G - K
Humaner Papillomavirus-Impfstoff 9-valent (Gardasil 9®): RMP summary (PDF, 265 kB, 18.08.2021)Version 4.1
HYNIC-D-Phe 1 Tyr 3- octeotridum_trifluoroacetum (Tektrotyd®): RMP summary (PDF, 201 kB, 30.11.2015)Version 1.0
L - N
measles, mumps, rubella and varicella virus (Priorix Tetra®): RMP Summary (PDF, 186 kB, 01.12.2019)Version 1.0
MENINGOCOCCAL POLYSACCHARIDE A, C, W-135 AND Y (Menquadfi)®) RMP Summary (PDF, 198 kB, 29.11.2022)Version 1.0
Methylthioninium chloride (Methylthioninumchlorid Proveblue®) RMP Summary (PDF, 191 kB, 01.10.2020)Version 1.0
O - R
Quatrivalent Influenza Vaccine_cell based (Flucelvax Tetra®) RMP Summary (PDF, 307 kB, 07.06.2021)Version 1.0
Quadrivalent Recombinant Influenca Vaccine (Supemtek®) RMP Summary (PDF, 163 kB, 22.03.2021)Version 1.0
Pertuzumab_Trastuzumab (Phesgo®) RMP Summary-rmpsummary20210607 (PDF, 395 kB, 07.06.2021)Version 1.0
S - U
Tepotinibum_Tepotinibi Hydrochloridum Monohydricum (Tepmetko®) RMP Summary (PDF, 192 kB, 01.02.2021)Version 4.0
V - Z
Sorted...
Sorted by product name
A - C
Diphtheria-2/Tetanus/5AC Pertussis Vaccine (Adacel®) RMP Summary (PDF, 122 kB, 17.10.2022)Version 5.0
Complexus toxini botulinici A_Haemagglutinini (Alluzience®) RMP Summary (PDF, 82 kB, 13.07.2020)Version 7.3
D - F
Quatrivalent Influenza Vaccine_cell based (Flucelvax Tetra®) RMP Summary (PDF, 307 kB, 07.06.2021)Version 1.0
G - K
Humaner Papillomavirus-Impfstoff 9-valent (Gardasil 9®): RMP summary (PDF, 265 kB, 18.08.2021)Version 4.1
L - N
MENINGOCOCCAL POLYSACCHARIDE A, C, W-135 AND Y (Menquadfi)®) RMP Summary (PDF, 198 kB, 29.11.2022)Version 1.0
Methylthioninium chloride (Methylthioninumchlorid Proveblue®) RMP Summary (PDF, 191 kB, 01.10.2020)Version 1.0
O - R
Emtricitabine Rilpivirine Tenofovir Alafenamide (Odefsey®): RMP (PDF, 104 kB, 01.05.2021)Version 3.0
Pertuzumab_Trastuzumab (Phesgo®) RMP Summary-rmpsummary20210607 (PDF, 395 kB, 07.06.2021)Version 1.0
measles, mumps, rubella and varicella virus (Priorix Tetra®): RMP Summary (PDF, 186 kB, 01.12.2019)Version 1.0
S - U
elasomeran (Spikevax®) / elasomeran / imelasomeran (Spikevax®) RMP Summary (PDF, 222 kB, 20.10.2022)Version 2.0
Quadrivalent Recombinant Influenca Vaccine (Supemtek®) RMP Summary (PDF, 163 kB, 22.03.2021)Version 1.0
autologus anti CD 19 transduced CD3 cells (Tecartus®) RMP Summary (PDF, 183 kB, 26.10.2021)Version 1.0
HYNIC-D-Phe 1 Tyr 3- octeotridum_trifluoroacetum (Tektrotyd®): RMP summary (PDF, 201 kB, 30.11.2015)Version 1.0
Tepotinibum_Tepotinibi Hydrochloridum Monohydricum (Tepmetko®) RMP Summary (PDF, 192 kB, 01.02.2021)Version 4.0
Last modification 19.01.2023